Cologne BioEcho Life Sciences GmbH, an innovative manufacturer of nucleic acid purification solutions for molecular diagnostics and life sciences research, today announced a minority investment from Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors. Ampersand’s investment will be used to support the company’s worldwide [...]

Asynt has introduced a versatile new kit for labs conducting low temperature chemistry – the DrySyn SnowStorm MULTI Starter Kit. Developed as a useful addition to Asynt’s popular low temperature chemistry product range - the DrySyn SnowStorm MULTI Starter Kit enables users to perform parallel reactions from ambient to -30 ⁰C within a small footprint. [...]

NHS England and NHS Improvement sign two-year deal for QIAGEN’s HGMD bioinformatics HGMD (Human Gene Mutation Database) will be used at seven sites to aid interpretation of genomic data from next-generation sequencing (NGS) Deal highlights HGMD's lead role interpreting NGS results for inherited diseases NGS data from over 2.5 million clinical cases now analyzed and [...]

Next-generation mid-pilot scale peptide synthesizer provides more reliable, robust, and improved workflows  Uppsala, Sweden: Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, today announced the launch of PurePep® Sonata®+, a mid-pilot scale peptide synthesizer. The new system is an upgraded version of the Company’s previous model, [...]

Thermo Fisher and Symphogen extend their collaboration using innovative and efficient workflows to improve data confidence, aiding the creation of new cancer treatments SAN JOSE, Calif. – Thermo Fisher Scientific, the world leader in serving science, and Symphogen, an affiliate of and the antibody center of excellence within the international pharmaceutical company Servier, announce the [...]

New Inspyra module combines chemists’ expertise with exploratory capabilities of automated compound design Inspyra provides drug designers direct access to powerful AI capabilities, supporting established workflow CAMBRIDGE, UK: Optibrium Ltd, a leading developer of software for drug discovery, today announced the release of the latest version of StarDrop™, its comprehensive software platform for small molecule design, [...]

sparQ RNA-Seq HMR Kit generates high-quality Illumina® NGS sequencer-ready libraries from intact or degraded samples in a single day BEVERLY, Mass. – Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced the commercial availability of the sparQ RNA-Seq HMR Kit, an [...]

Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a partnership with Genoox, a community-driven genomic data platform, to demonstrate the clinical potential of the AVITI™ system for rare and undiagnosed disease research, using whole-genome sequencing. An initial study, in collaboration with Dr. Radha Ayyagari, Professor of Ophthalmology and Pathology at the [...]

License agreement provides Quanterix access to Lilly’s P-tau217 antibody technology, creating pathways for plasma-based biomarkers for use in Alzheimer’s disease; Establishes framework for future collaboration and supports development of Quanterix tests to advance diagnosing and treating life-threatening diseases Billerica, Mass. – Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision [...]

Masoud Toloue, President of Quanterix and Diagnostics, to Become CEO and Join Board of Directors Kevin Hrusovsky, Chairman and CEO of Quanterix, to Assume Role as Executive Chairman of the Board Moves are Designed to Propel the Precision Health Vision and Catalyze the Next Chapter of Growth and Impact Billerica, Mass. – Quanterix Corporation (NASDAQ: QTRX), [...]